Disease/Infection News

RSS

Studies analyze epidemiologic supervision and influenza cases among children in Catalonia

The viral infections of the upper respiratory tract are an important cause of morbidity and mortality worldwide and, among them, influenza is one of the most important ones, with severe cases ranging from three and five million cases, and between 290,000 and 650,000 deaths per year. This is why a proper supervision of the disease is crucial.

24 Feb 2020

Harvard scientists will join forces with Chinese colleagues on coronavirus research

Since its identification in December, the novel coronavirus has quickly evolved into a global threat, taking a toll on human health, overwhelming vulnerable health care systems and destabilizing economies worldwide.

24 Feb 2020

New tool incorporates PET and CT scans to measure effectiveness of key anti-TB medicine

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.

24 Feb 2020

Coronavirus incubation period could be 27 days, longer than previously thought

Over the past weeks, health officials around the globe traced and advised suspected contacts of people with the coronavirus disease (COVID-19) to isolate themselves for 14 days, the incubation period of the disease.

24 Feb 2020

Italy grapples with the largest coronavirus outbreak in Europe

In just a matter of days, Italy has reported an increasing number of cases linked to the novel coronavirus that is spreading rapidly across the globe. The coronavirus disease (COVID-19) has emerged in China late in December 2019 and has so far reached 30 countries.

23 Feb 2020

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Back in February 2018, the World Health Organization (WHO) talked about a new virus that will emerge and wreak havoc across the globe. Disease X was the term used for this new unknown pathogen that might cause a future epidemic.

23 Feb 2020

Consumers more likely to purchase cold and flu products over coronavirus fears, says GlobalData

The start of 2020 has been defined by Coronavirus, which to date has killed over 1,000 people and impacted the lives of thousands more.

21 Feb 2020

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

21 Feb 2020

Study shows main gates for coronavirus importation in Africa

Egypt, Algeria and Republic of South Africa are the African countries most at risk for coronavirus COVID-19 importation in the continent, due to high air traffic with the contaminated Chinese provinces.

20 Feb 2020

New study uncovers human genes controlling HIV infection

Viruses are parasites. The only way they can grow is by hijacking their hosts. When they infect a human host, viruses use human proteins to multiply and modify the human cells to sustain the infection. At the same time, the human host activates defense mechanisms to fight the infection.

20 Feb 2020

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.

20 Feb 2020

Researchers develop pill-sized heating device for point-of-care applications

Researchers at the University of Toronto Engineering have developed a tiny "heater" - about the size of a pill - that could allow resource-limited regions around the world to test for infectious diseases without the need for specialized training or costly lab equipment.

20 Feb 2020

Purdue scientists receive $3.2 million NIH grant to target antimicrobial resistance

New support may help Purdue University scientists target what they call one of the greatest threats to human health - antimicrobial resistance.

20 Feb 2020

African countries at highest risk when the coronavirus spreads

/news/20200220/Study-Egypt-Algeria-and-South-Africa-at-highest-risk-of-importing-COVID-19-cases-from-China.aspx

20 Feb 2020

Innovative breath collecting device could change coronavirus diagnosis around the world

An innovative breath collecting device developed by academics at Northumbria University, Newcastle, could revolutionize the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19.

19 Feb 2020

Using a 'big data' approach to treat sepsis more effectively

Sepsis is a serious medical condition caused by an overwhelming response to infection that damages tissues and organs.

19 Feb 2020

Vaccine for COVID-19 coronavirus could soon be a reality

A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.

19 Feb 2020

Setting the record straight: Indigenous STIs and sexual abuse

Young Aboriginal and Torres Strait Islander people are being discouraged from seeking medical help due to public assumptions that sexually transmissible infections are the result of sexual abuse.

19 Feb 2020

How malaria evades the body’s immune response

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. In 2018, there were over 200 million cases of malaria worldwide. Now, a team of researchers found evidence that the malaria parasite can detect a molecule released by approaching immune cells, using it to protect itself and evade the attack by the body’s immune system.

19 Feb 2020

Coronavirus is deadlier than flu with seniors at highest risk

The novel coronavirus (CoV) is a new strain of coronavirus that has not been previously identified in humans. The new, or “novel” coronavirus, now called 2019-nCoV, had not previously detected before the outbreak was reported in Wuhan, China in December 2019.

19 Feb 2020

Disease/Infection News

Studies analyze epidemiologic supervision and influenza cases among children in Catalonia

Harvard scientists will join forces with Chinese colleagues on coronavirus research

New tool incorporates PET and CT scans to measure effectiveness of key anti-TB medicine

Coronavirus incubation period could be 27 days, longer than previously thought

Italy grapples with the largest coronavirus outbreak in Europe

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Consumers more likely to purchase cold and flu products over coronavirus fears, says GlobalData

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

Study shows main gates for coronavirus importation in Africa

New study uncovers human genes controlling HIV infection

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

Researchers develop pill-sized heating device for point-of-care applications

Purdue scientists receive $3.2 million NIH grant to target antimicrobial resistance

African countries at highest risk when the coronavirus spreads

Innovative breath collecting device could change coronavirus diagnosis around the world

Using a 'big data' approach to treat sepsis more effectively

Vaccine for COVID-19 coronavirus could soon be a reality

Setting the record straight: Indigenous STIs and sexual abuse

How malaria evades the body’s immune response

Coronavirus is deadlier than flu with seniors at highest risk

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News